GENELUX Corp

GNLX Nasdaq SEC CIK 1231457
Follow Genelux Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$10.3M −29.4% vs same quarter last year
EPS, diluted −$0.23 −9.5% vs same quarter last year
Operating cash flow −$5.9M +9.9% vs same quarter last year
Operating income −$10.4M −26.9% vs same quarter last year
Net income by quarter
−$9M
−$7.5M
−$7.5M
−$8M
−$9.2M
−$8.9M
−$9.5M
−$10.3M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income5 fiscal years
  • Revenue
  • Net income
−$40M−$20M$0$20MFY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$8K−$32.1M
FY24$8K−$29.9M
FY23$170K−$28.3M
FY22$11.1M−$5.2M
FY21--
MarginsShare of revenue
  • Operating margin
  • Net margin
−600000%−400000%−200000%0%FY21FY22FY23FY24FY25
Show the numbers
YearOperating marginNet margin
FY25−415175%−401812.5%
FY24−396200%−373362.5%
FY23−14214.7%−16645.3%
FY22−27.2%−47%
FY21--
Free cash flowOperating cash flow minus capital expenditure
−$30M−$20M−$10M$0FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$26.4M
FY24−$21.6M
FY23−$21.3M
FY22−$3.6M
FY21-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Genelux
  • Healthcare median
−600000%−400000%−200000%0%FY21FY22FY23FY24FY25
Show the numbers
YearGeneluxHealthcare median
FY25−401812.5%−30.6%
FY24−373362.5%−47%
FY23−16645.3%−58%
FY22−47%−80.4%
FY21-−71.9%